|
1
|
Knopf A, Lempart J, Bas M,
Slotta-Huspenina J, Mansour N and Fritsche MK: Oncogenes and tumor
suppressor genes in squamous cell carcinoma of the tongue in young
patients. Oncotarget. 6:3443–3451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taguchi T, Nishimura G, Takahashi M,
Komatsu M, Sano D, Sakuma N, Arai Y, Yamashita Y, Shiono O, Hirama
M, et al: Treatment results and prognostic factors for advanced
squamous cell carcinoma of the larynx treated with concurrent
chemoradiotherapy. Cancer Chemother Pharmacol. 72:837–843. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zitelli KB, Zedek D, Ranganathan P and
Amerson EH: Squamous cell carcinoma of the lip associated with
adalimumab therapy for ankylosing spondylitis: A case report and
review of TNF-α inhibitors and cutaneous carcinoma risk. Cutis.
92:35–39. 2013.PubMed/NCBI
|
|
4
|
Dionne KR, Warnakulasuriya S, Zain RB and
Cheong SC: Potentially malignant disorders of the oral cavity:
Current practice and future directions in the clinic and
laboratory. Int J Cancer. 136:503–515. 2015.
|
|
5
|
Wenig BM: Squamous cell carcinoma of the
upper aerodigestive tract: Precursors and problematic variants. Mod
Pathol. 15:229–254. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han S, Chen Y, Ge X, Zhang M, Wang J, Zhao
Q, He J and Wang Z: Epidemiology and cost analysis for patients
with oral cancer in a university hospital in China. BMC Public
Health. 10:1962010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fury MG, Xiao H, Sherman EJ, Baxi S,
Smith-Marrone S, Schupak K, Gewanter R, Gelblum D, Haque S, Schoder
H, et al: A phase II trial of bevacizumab + cetuximab + cisplatin
with concurrent intensity modulated radiation therapy (IMRT) for
patients with stage III/IVB head and neck squamous cell carcinoma
(HNSCC). Head Neck. Mar 17–2015.Epub ahead of print. View Article : Google Scholar
|
|
8
|
Simpson DR, Mell LK and Cohen EE:
Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of
the head and neck. Oral Oncol. 51:291–298. 2015. View Article : Google Scholar
|
|
9
|
Sagara N, Toda G, Hirai M, Terada M and
Katoh M: Molecular cloning, differential expression, and
chromosomal localization of human frizzled-1, frizzled-2, and
frizzled-7. Biochem Biophys Res Commun. 252:117–122. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peifer M and Polakis P: Wnt signaling in
oncogenesis and embryogenesis - a look outside the nucleus.
Science. 287:1606–1609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ueno K, Hirata H, Hinoda Y and Dahiya R:
Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.
Int J Cancer. 132:1731–1740. 2013. View Article : Google Scholar
|
|
12
|
Lee HC, Kim M and Wands JR: Wnt/Frizzled
signaling in hepatocellular carcinoma. Front Biosci. 11:1901–1915.
2006. View Article : Google Scholar
|
|
13
|
Hlubek F, Spaderna S, Schmalhofer O, Jung
A, Kirchner T and Brabletz T: Wnt/FZD signaling and colorectal
cancer morphogenesis. Front Biosci. 12:458–470. 2007. View Article : Google Scholar
|
|
14
|
Gurney A, Axelrod F, Bond CJ, Cain J,
Chartier C, Donigan L, Fischer M, Chaudhari A, Ji M, Kapoun AM, et
al: Wnt pathway inhibition via the targeting of Frizzled receptors
results in decreased growth and tumorigenicity of human tumors.
Proc Natl Acad Sci USA. 109:11717–11722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding LC, Huang XY, Zheng FF, Xie J, She L,
Feng Y, Su BH, Zheng DL and Lu YG: FZD2 inhibits the cell growth
and migration of salivary adenoid cystic carcinomas. Oncol Rep. Feb
19–2015.Epub ahead of print. View Article : Google Scholar
|
|
16
|
Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin
J, Corr M and Carson DA: Wnt and frizzled receptors as potential
targets for immunotherapy in head and neck squamous cell
carcinomas. Oncogene. 21:6598–6605. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prgomet Z, Axelsson L, Lindberg P and
Andersson T: Migration and invasion of oral squamous carcinoma
cells is promoted by WNT5A, a regulator of cancer progression. J
Oral Pathol Med. Dec 2–2014.Epub ahead of print. PubMed/NCBI
|
|
18
|
Schefe JH, Lehmann KE, Buschmann IR, Unger
T and Funke-Kaiser H: Quantitative real-time RT-PCR data analysis:
Current concepts and the novel 'gene expression's CT difference'
formula. J Mol Med Berl. 84:901–910. 2006. View Article : Google Scholar
|
|
19
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Goor H, Melenhorst WB, Turner AJ and
Holgate ST: Adamalysins in biology and disease. J Pathol.
219:277–286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bonnans C, Chou J and Werb Z: Remodelling
the extracellular matrix in development and disease. Nat Rev Mol
Cell Biol. 15:786–801. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mochizuki S and Okada Y: ADAMs in cancer
cell proliferation and progression. Cancer Sci. 98:621–628. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Díaz Prado SM, Medina Villaamil V,
Aparicio Gallego G, Blanco Calvo M, López Cedrún JL, Sironvalle
Soliva S, Valladares Ayerbes M, García Campelo R and Antón Aparicio
LM: Expression of Wnt gene family and frizzled receptors in head
and neck squamous cell carcinomas. Virchows Arch. 455:67–75. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang YX, Yu SB, Ou-Yang JP, Xia D, Wang M
and Li JR: Effect of protein kinase C alpha, caspase-3, and
survivin on apoptosis of oral cancer cells induced by
staurosporine. Acta Pharmacol Sin. 26:1365–1372. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang RY, Guilford P and Thiery JP: Early
events in cell adhesion and polarity during epithelial-mesenchymal
transition. J Cell Sci. 125:4417–4422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gujral TS, Chan M, Peshkin L, Sorger PK,
Kirschner MW and MacBeath G: A noncanonical Frizzled2 pathway
regulates epithelial-mesenchymal transition and metastasis. Cell.
159:844–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Orgaz JL, Pandya P, Dalmeida R,
Karagiannis P, Sanchez-Laorden B, Viros A, Albrengues J, Nestle FO,
Ridley AJ, Gaggioli C, et al: Diverse matrix metalloproteinase
functions regulate cancer amoeboid migration. Nat Commun.
5:42552014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chiang WC, Wong YK, Lin SC, Chang KW and
Liu CJ: Increase of MMP-13 expression in multi-stage oral
carcinogenesis and epigallocatechin-3-gallate suppress MMP-13
expression. Oral Dis. 12:27–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Henriques AC, de Matos FR, Galvão HC and
Freitas RA: Immunohistochemical expression of MMP-9 and VEGF in
squamous cell carcinoma of the tongue. J Oral Sci. 54:105–111.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruokolainen H, Pääkkö P and
Turpeenniemi-Hujanen T: Tissue and circulating immunoreactive
protein for MMP-2 and TIMP-2 in head and neck squamous cell
carcinoma - tissue immunoreactivity predicts aggressive clinical
course. Mod Pathol. 19:208–217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Filou S, Stylianou M, Triantaphyllidou IE,
Papadas T, Mastronikolis NS, Goumas PD, Papachristou DJ, Ravazoula
P, Skandalis SS and Vynios DH: Expression and distribution of
aggrecanases in human larynx: ADAMTS-5/aggrecanase-2 is the main
aggrecanase in laryngeal carcinoma. Biochimie. 95:725–734. 2013.
View Article : Google Scholar
|
|
36
|
Grumolato L, Liu G, Mong P, Mudbhary R,
Biswas R, Arroyave R, Vijayakumar S, Economides AN and Aaronson SA:
Canonical and noncanonical Wnts use a common mechanism to activate
completely unrelated coreceptors. Genes Dev. 24:2517–2530. 2010.
View Article : Google Scholar : PubMed/NCBI
|
